Ownership history in WINTON GROUP Ltd Β· 14 quarters on record
This page tracks every 13F SEC filing in which WINTON GROUP Ltd reported a position in COLLEGIUM PHARMACEUTICAL INC (COLL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π WINTON GROUP Ltd outperformed the S&P 500 by +16.7% annually on this COLL position. Timing score: 46% (6/13 decisions correct). Average cost basis: $22.04. Maximum drawdown during holding period: β25.0%.
π₯ Exceptional β beat the S&P 500 by 16.7% per year on this position.
13 quarters analyzed
β‘οΈ Neutral timing β roughly coin-flip accuracy on add/trim calls.
6 of 13 add/trim decisions correct
Best entry: $11.48 (2019 Q3) Β· Worst: $38.82 (2024 Q1)
πͺ Held through 2 major drawdowns (>20%).
7 adds Β· 7 trims. Bought during 2 of 6 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.09% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size